Earnings NYSE Nasdaq 100 U.S. Tech Politics AI Science SEC Business Wall Street Energy Bitcoin (BTC) Dow Jones Dividend NVIDIA (NVDA) Investing Markets Economy S&P 500 China World Donald Trump Fed Crude Oil Money Inflation Tesla (TSLA) Gold Software U.K. Entertainment Apple (AAPL) Health Amazon (AMZN) Retail Wealth Taxes Elon Musk Europe Real Estate Retirement Natural Gas 3M (MMM) Microsoft (MSFT) Security Meta Platforms (META) Current Canada Options Truist Financial Corp (TFC) Boeing (BA) Hedge Funds Jim Cramer Tax Insurance Google Sports Live Manufacturing Cars Pharmaceuticals Economics War Warren Buffett Ukraine Airlines Costco (COST) Mining Holidays Finance Japan York Silver Construction Goldman Sachs (GS) Interest Rates New York BlackRock (BLK) Walmart (WMT) Kamala Harris OpenAI ChatGPT Space REITs Mortgage Internet JPMorgan (JPM) Ethereum (ETH) Aerospace Enterprise Intel (INTC) Walt Disney (DIS) GBP USD Netflix (NFLX) India Texas IPOs Morgan Stanley (MS) AustraliaMore +
Stock Market News Stock Market News
  • Stocks
  • ETFs
  • Bonds
  • Commodities
  • Earnings
  • Dividends
  • REITs
  • IPOs
  • Cryptocurrency
  • Forex
  • Tech
  • Politics
  • +

1 month The term premium and the bond vigilantesFinancial Times

Plus more on Pfizer

Pfizer (PFE)

X       

1 day Pharma Stock Roundup: EU Nod for PFE’s Hympavzi, NVS Ups Sales ViewZacks X       

1 day Pfizer Inc. (PFE) Jefferies London Healthcare Conference (Transcript)Seeking Alpha X       

2 days Pfizer: High Dividend And Low Price Might Still Offset The Expanding RisksSeeking Alpha X       

3 days PFE vs. NVO: Which Stock Is the Better Value Option?Zacks X       

3 days The Zacks Analyst Blog Highlights Adobe, Pfizer, Dollar General, Snap and RyanairZacks X       

3 days Pfizer Secures Approval for Hemophilia Drug Hympavzi in the EUZacks X       

4 days Pfizer names oncology head Chris Boshoff as R&D chiefInvesting.com X       

4 days Pfizer names oncology chief and company veteran Boshoff as chief scientific officerMarketWatch X       

4 days Pfizer Names New R&D ChiefThe Wall Street Journal X       

4 days Is It Time to Sell Eli Lilly and Pfizer Stocks?The Motley Fool X       

4 days Is It Time to Sell Eli Lilly and Pfizer Stocks?Yahoo Finance X       

4 days Pfizer cannot recoup $75 million from SEC insider trading settlement, judge rulesYahoo Finance X       

5 days The Zacks Analyst Blog Highlights Pfizer, Newmont, Uber, Adobe and QualcommZacks X       

5 days Jim Cramer on Pfizer Inc. (PFE): ‘Still, Anything Good There, It Could Fly’Insider Monkey X       

1 week Pfizer- am I stuck with take lock or is this a great value?Reddit X       

1 week Pfizer (PFE) is a Top-Ranked Value Stock: Should You Buy?Zacks X       

1 week Moderna, Lily, Novavax, and Pfizer stocks fall after Trump nominates RFK Jr. as health secretaryFast Company X       

1 week Pfizer, Moderna, BioNTech Take A Beating After Trump Taps Kennedy To Head Up HHSInvestor's Business Daily X       

1 week Pfizer Inc. (PFE) Is a Trending Stock: Facts to Know Before Betting on ItZacks X       

1 week Court Hears New York Times Case Against European Commission Over Vaccine DealThe New York Times X       

1 week Vaccine-maker stocks like Moderna, Pfizer drop as Trump picks RFK Jr. to lead HHSMarketWatch X       

1 week Vaccine maker stocks fall as Trump chooses RFK Jr. to lead HHSCNBC X       

1 week Is Pfizer Stock A Sell With Vaccine Skeptic Robert F. Kennedy Jr. Tapped To Lead HHS?Investor's Business Daily X       

1 week Is Pfizer Inc. (PFE) Among The Top Dividend Contenders Right Now?Insider Monkey X       

1 week The Oncology Bet Is Already Paying Off For PfizerYahoo Finance X       

1 week Pfizer Inc. (PFE) UBS Global Healthcare Conference (Transcript)Seeking Alpha X       

2 weeks Zacks.com featured highlights include StoneCo, Skechers, Pfizer and General MotorsZacks X       

2 weeks 3 Stocks Seeing Insider Buys: CNC, PFE, BMYZacks X       

2 weeks Exclusive-Pfizer explores sale of hospital drugs unit, sources sayYahoo Finance X       

2 weeks Should Value Investors Buy Pfizer (PFE) Stock?Zacks X       

2 weeks AbbVie And Pfizer: Q3 Dividend Checkup Post-EarningsSeeking Alpha X       

2 weeks Pfizer Inc. (PFE): Among the Best Low Volatility Stocks to Invest In NowInsider Monkey X       

2 weeks 3 Reasons Pfizer Looks Like a No-Brainer Buy Right NowThe Motley Fool X       

3 weeks PFE or NVO: Which Is the Better Value Stock Right Now?Zacks X       

3 weeks 1 Green Flag That’s Also a Red Flag for Pfizer StockThe Motley Fool X       

3 weeks Buy, Sell or Hold Pfizer Stock After Q3 Earnings Beat, Guidance Boost?Zacks X       

3 weeks Is Pfizer Stock a Bargain for Long-Term Investors?The Motley Fool X       

3 weeks This Beaten-Down Stock Just Gave Investors More Good News: Is it a Buy?The Motley Fool X       

3 weeks 3 Potential Catalysts That Could Lift Pfizer Stock Before 2025The Motley Fool X       

3 weeks Pfizer Is A Good Stock To Buy After The EarningsSeeking Alpha X       

3 weeks Pharma Stock Roundup: MRK, PFE, ABBV, NVS, LLY’s Q3 Earnings in FocusZacks X       

3 weeks Pfizer Inc. (NYSE:PFE) Director Acquires $28,240.00 in StockMarketBeat X       

3 weeks Is Pfizer (NYSE:PFE) a High-Yielding Dividend Stock Worth Buying?Yahoo Finance X       

3 weeks Pfizer (NYSE:PFE) Stock Price Down 0.4% – Should You Sell?MarketBeat X       

3 weeks Pfizer CEO discusses Q3 earnings, ‘exceptional’ growthYouTube X       

3 weeks Zacks Investment Ideas feature highlights: Pfizer, Philip Morris and Tenet HealthcareZacks X       

3 weeks 3 Factors That Make Pfizer’s Ultra-High-Yield Dividend Safer Than You Might ThinkThe Motley Fool X       

3 weeks Amgen ‘Laser-Focused’ On Its Weight-Loss Shot As New Rival Pfizer Follows, Says CFOInvestor's Business Daily X       

3 weeks Pfizer (NYSE:PFE) Stock Price Down 0.7% – Here’s What HappenedMarketBeat X       

4 weeks 3 Stocks to Buy Following Robust Quarterly ResultsZacks X       

More news +
Home | Contact
  • X

© 2024 The Stock Market News